Humatrope is a synthetic human growth hormone that was first developed in 1978. It was developed for individuals who have a growth hormone deficiency, and can be used in children and adults. It is delivered via injection as Somatropin. Designed to stimulate the production of growth hormones, Humatrope is a replacement for those with a lack of naturally-occurring human growth hormone when levels of the hormone are insufficient to stimulate appropriate growth.
How Humatrope Works
Human growth hormone is essential for growth. Lack of production of this hormone in children or adults results in growth deficiencies that affect health, quality of life and life expectancy. Certain growth markers are measured throughout an individual’s life. Failure to meet the base markers for age and gender may result in a need for medical intervention.
Humatrope stimulates the production of insulin-like growth factor one (IGF-1), another hormone that is responsible for growth. The synthetic hormone was designed to replace human growth hormone for individuals that do not produce enough of the hormone on their own to trigger appropriate growth levels.
Conditions Treated By Humatrope
– Growth hormone deficiency
– SHOX deficiency
– Turner Syndrome
-Ideopathic Short Stature, children who are shorter than 98.8% of their peers
– Children who have not reached target growth projections by 2 to 4 years of age, and were born smaller than is typical for the number of weeks of gestation
– Pituitary disease in adults
– Hypothalmic disease in adults
– Hormone deficiency related to radiation therapy
– Trauma-related hormone deficiency
– Other hgh-deficiency-related conditions
How is Humatrope Delivered
Somatropin is delivered via injection. It is available in 6 mg, 12 mg, and 24 mg cartridges for use in a Humatropen. It can also be purchased in vial form, and delivered with a syringe and medical needle.
Storage of Humatrope
Humatrope should be kept refrigerated both before and after it is mixed. Ideal temperatures are 36 degrees Fahrenheit to 42 degrees Fahrenheit (2-8 degrees Celsius.) Once it has been mixed, it should be used within 28 days if in cartridge form, and 14 days if in vial form.
Do not use Humatrope if the following conditions are present:
– Complications after a major surger
– Children with Prader-Willi Syndrome
– Blocked or damaged airways
– Allergies to growth hormone
Patients Should be Monitored for the Following Conditions
– Increased blood sugar levels
– Water retention
– Visual changes
– Thyroid hormone level changes
– Complaints of hip pain or a limp
– Scoliosis progression
– Abdominal pain
– Breakdown of skin at injection site
Available by prescription only.